Defining reality: the potential role of pharmacists in assessing the impact of progesterone receptor modulators and misoprostol in reproductive health.

Harrison, Donna J; Mitroka, James G

Harrison, Donna J; Mitroka, James G.

Affiliation

Harrison DJ; American Association of Pro-Life Obstetricians and Gynecologists, Holland, MI, USA. djhobgyn@wildblue.net

Ann Pharmacother ; 45(1): 115-9, 2011 Jan.

Article in En | MEDLINE | ID: mdl-21177418

Subject(s)

Abortifacient Agents/adverse effects; Abortifacient Agents/therapeutic use; Misoprostol/adverse effects; Pharmacists; Professional Role; Receptors, Progesterone/agonists; Receptors, Progesterone/antagonists & inhibitors; Abortifacient Agents/pharmacology; Contraceptives, Postcoital, Synthetic/adverse effects; Contraceptives, Postcoital, Synthetic/pharmacology; Contraceptives, Postcoital, Synthetic/therapeutic use; Female; Health Policy; Humans; Mifepristone/adverse effects; Mifepristone/pharmacology; Mifepristone/therapeutic use; Misoprostol/pharmacology; Misoprostol/therapeutic use; Nonprescription Drugs/adverse effects; Nonprescription Drugs/pharmacology; Nonprescription Drugs/therapeutic use; Norpregnadienes/adverse effects; Norpregnadienes/pharmacology; Norpregnadienes/therapeutic use; Off-Label Use; Product Surveillance, Postmarketing/trends; Reproductive Medicine/trends; Risk Assessment/trends; United States; United States Food and Drug Administration

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pharmacists / Abortifacient Agents / Receptors, Progesterone / Misoprostol / Professional Role Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans Country/Region as subject: America do norte Language: En Year: 2011 Type: Article

Fulltext

XML

PubMed Links

Search on Google